Dose Effect of Cis- and Trans-Encoded HLA-DQαβ Heterodimers in IDDM Susceptibility

Insulin-dependent diabetes mellitus (IDDM) in whites is strongly associated with particular HLA-DQαβ heterodimers composed of a DQα chain with anrginine at residue 52 (Arg52+) combined to a DQβ chain lacking an aspartic acid at residue 57 (Asp57−. With the aim of confirming this association, clarifying which heterodimers account for the highest risk of IDDM and explaining the excess risk of DR3-DQw2/DR4-DQw8,115 unrelated white IDDM patients and 108 unrelated healthy nondiabetic control subjects were studied. With polymerase chain reaction and sequence-specific oligonucleotide probes, both patients and control subjects were typed for their HLA-DQA1 and DQB1 alleles and their DQA1-DQB1 haplotype and genotype frequencies were compared. Four major findings emerged from our analysis. 1) Arg52+ DQα/Asp57− Dβp heterodimers, formed in cis and/r in trans, are strongly associated with susceptibility to IDDM; 97% of patients and 46% of control subjects had at least one such susceptibility heterodimer (relative risk [RR] 32, confidence interval [Cl] 14.25–71.86, P < 10−. 2) The degree of disease susceptibility depends on the number of such DQ heterodimers that a subject can express according to his or her DQA1-DQB1 genotype. The highest RR was observed in patients with four susceptibility DQ heterodimers (RR 41, Cl 17.05–95.9). 3) Only part of the susceptibility DQ heterodimers were significantly increased in patients, conferring IDDM susceptibility of different strength. The strongest association was with the DQA1*0501-DQB1*0302 combination formed in trans position (RR 35.2, Cl 12.88–96.78, P < 10−7). 4) The simultaneous expression of four different susceptibility heterodimers explains the highest risk of DR3-DQw2/DR4-DQw8 heterozygotes. In conclusion, there is a dose effect of cis- and trans-encoded HLA-DQαβ heterodimers in IDDM susceptibility influenced by the diversity of these molecules.

[1]  E. Thorsby,et al.  Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. , 1991, Tissue antigens.

[2]  A. Ridderstad,et al.  Speculations on Mechanisms of HLA Associations with Autoimmune Diseases and the Specificity of “Autoreactive” T Lymphocytes , 1990, Immunological reviews.

[3]  E. Thorsby,et al.  Recognition of a particular HLA‐DQ heterodimer by a human γ/δ T cell clone , 1990 .

[4]  J. D. Capra,et al.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.

[5]  J. Todd,et al.  The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Thorsby,et al.  The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. , 1989, Human immunology.

[7]  J. Todd,et al.  Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping , 1989, Nature.

[8]  B. Dupont,et al.  Description of the Reference Panel of B-Lymphoblastoid Cell Lines for Factors of the HLA System: The B-Cell Line Panel Designed for the Tenth International Histocompatibility Workshop , 1989 .

[9]  H. Erlich,et al.  Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Klitz.  Inheritance of insulin-dependent diabetes , 1988, Nature.

[11]  I. Deschamps,et al.  Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. , 1988, Tissue antigens.

[12]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[13]  M. Jeanpierre.  A rapid method for the purification of DNA from blood. , 1987, Nucleic acids research.

[14]  G. Nepom,et al.  Transcomplementation of HLA Genes in IDDM: HLA-DQ α and β-Chains Produce Hybrid Molecules in DR3/4 Heterozygotes , 1987, Diabetes.

[15]  Henry A. Erlich,et al.  Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.

[16]  J. R. Rowe,et al.  A Particular Subset of HLA-DR4 Accounts for All or Most of the DR4 Association in Type I Diabetes , 1985, Diabetes.

[17]  S. Rich,et al.  Insulin-dependent diabetes--associated HLA-D region encoded determinants. , 1985, Human immunology.

[18]  V. Lotteau,et al.  Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation , 1984, Nature.

[19]  N. K. Jerne,et al.  Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice. , 1978, Proceedings of the National Academy of Sciences of the United States of America.